Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2021

Open Access 01-12-2021 | Mood Disorders | Research

Treatment adequacy and remission of depression and anxiety disorders and quality of life in primary care older adults

Authors: Catherine Lamoureux-Lamarche, Djamal Berbiche, Helen-Maria Vasiliadis

Published in: Health and Quality of Life Outcomes | Issue 1/2021

Login to get access

Abstract

Background

Studies on the long-term outcomes of receiving adequate treatment for depression and anxiety disorders are scarce. The aims of this study were to assess the association between adequacy of care and remission of common mental disorders (CMD) and change in quality of life among a population of older adults consulting in primary care.

Methods

The study was conducted among 225 older adults with a CMD who participated in the longitudinal ESA-Services study. Adequacy of care was assessed using administrative and self-reported data and was based on Canadian guidelines and relevant literature. CMD were measured at baseline and follow-up using self-reported measures (DSM-5 criteria) and physician diagnostic codes (International Classification of Diseases, 9th and 10th revisions) for depression and anxiety disorders. The remission of CMD was defined by the presence of at least one disorder at baseline and absence at follow-up. Quality of life was measured at baseline and follow-up using a visual analog scale and the Satisfaction With Life Scale. To estimate the probability to receive adequate/inadequate care, a propensity score was calculated, and analyses were weighted by the inverse probability. Weighted multivariable analyses were carried out to assess the remission of CMD and change in quality of life as a function of adequacy of care controlling for individual and health system factors.

Results

Results showed that 40% of older adults received adequate care for CMD and 55% were in remission at follow-up. Adequacy of care was associated with remission of CMD (AOR: 0.66; CI 0.45–0.97; p-value: 0.032). Participants receiving adequate care had an improvement between baseline and follow-up of 0.7 (beta: 0.69, CI 0.18; 1.20, p = 0.008) point on the Satisfaction With Life Scale, while a marginal association was observed with improvement in HRQOL (beta: 2.83, CI 0.12; 5.79, p = 0.060).

Conclusion

The findings contribute to the rare observational studies on the association between adequacy of care for CMD and long-term treatment effects. Future studies on population effectiveness should focus on patient indicators of quality of care which may better predict long-term outcomes for patients with depression and anxiety.
Literature
1.
Smetanin P, Stiff D, Briante C, Adair CE, Ahmad S, Khan M: The life and economic impact of major mental illnesses in Canada: 2011 to 2041.; 2011.
2.
Verhaak PF, Prins MA, Spreeuwenberg P, Draisma S, van Balkom TJ, Bensing JM, Laurant MG, van Marwijk HW, van der Meer K, Penninx BW. Receiving treatment for common mental disorders. Gen Hosp Psychiatry. 2009;31:46–55.PubMedCrossRef
3.
Wang PS, Berglund P, Kessler RC. Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med. 2000;15:284–92.PubMedPubMedCentralCrossRef
4.
Byers AL, Yaffe K, Covinsky KE, Friedman MB, Bruce ML. High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication. Arch Gen Psychiatry. 2010;67:489–96.PubMedPubMedCentralCrossRef
5.
Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21:169–84.PubMedPubMedCentralCrossRef
6.
Mackenzie CS, El-Gabalawy R, Chou KL, Sareen J. Prevalence and predictors of persistent versus remitting mood, anxiety, and substance disorders in a national sample of older adults. Am J Geriatr Psychiatry. 2014;22:854–65.PubMedCrossRef
7.
Andreas S, Schulz H, Volkert J, Dehoust M, Sehner S, Suling A, Ausin B, Canuto A, Crawford M, Da Ronch C, et al. Prevalence of mental disorders in elderly people: the European MentDis_ICF65+ study. Br J Psychiatry. 2017;210:125–31.PubMedCrossRef
8.
Volkert J, Schulz H, Harter M, Wlodarczyk O, Andreas S. The prevalence of mental disorders in older people in Western countries - a meta-analysis. Ageing Res Rev. 2013;12:339–53.PubMedCrossRef
9.
Préville M, Boyer R, Grenier S, Dube M, Voyer P, Punti R, Baril MC, Streiner DL, Cairney J, Brassard J. Scientific Committee of the ESAS: The epidemiology of psychiatric disorders in Quebec’s older adult population. Can J Psychiatry. 2008;53:822–32.PubMedCrossRef
10.
Preville M, Boyer R, Vasiliadis HM, Grenier S, Streiner D, Cairney J, Brassard J. Scientific Committee of the ESAS: Persistence and remission of psychiatric disorders in the quebec older adult population. Can J Psychiatry. 2010;55:514–22.PubMedCrossRef
11.
Préville M, Vasiliadis HM, Boyer R, Goldfarb M, Demers K, Brassard J, Beland SG. Scientific Committee of the ESAS: Use of health services for psychological distress symptoms among community-dwelling older adults. Can J Aging. 2009;28:51–61.PubMedCrossRef
12.
Piek E, Nolen WA, van der Meer K, Joling KJ, Kollen BJ, Penninx BW, van Marwijk HW, van Hout HP. Determinants of (non-)recognition of depression by general practitioners: results of the Netherlands Study of Depression and Anxiety. J Affect Disord. 2012;138:397–404.PubMedCrossRef
13.
Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002;63(Suppl 8):24–34.PubMed
14.
Chapdelaine A, Carrier JD, Fournier L, Duhoux A, Roberge P: Treatment adequacy for social anxiety disorder in primary care patients. PLoS One 2018, 13:e0206357.
15.
Roberge P, Fournier L, Duhoux A, Nguyen CT, Smolders M. Mental health service use and treatment adequacy for anxiety disorders in Canada. Soc Psychiatry Psychiatr Epidemiol. 2011;46:321–30.PubMedCrossRef
16.
Smolders M, Laurant M, Verhaak P, Prins M, van Marwijk H, Penninx B, Wensing M, Grol R. Adherence to evidence-based guidelines for depression and anxiety disorders is associated with recording of the diagnosis. Gen Hosp Psychiatry. 2009;31:460–9.PubMedCrossRef
17.
Weisberg RB, Beard C, Moitra E, Dyck I, Keller MB. Adequacy of treatment received by primary care patients with anxiety disorders. Depress Anxiety. 2014;31:443–50.PubMedCrossRef
18.
Duhoux A, Fournier L, Gauvin L, Roberge P. Quality of care for major depression and its determinants: a multilevel analysis. BMC Psychiatry. 2012;12:142.PubMedPubMedCentralCrossRef
19.
Massamba V, Vasiliadis H-M, Préville M. Determinants of follow-up care associated with incident antidepressant use in older adults. BMC Res Notes. 2017;10:419.PubMedPubMedCentralCrossRef
20.
Meyers BS, Sirey JA, Bruce M, Hamilton M, Raue P, Friedman SJ, Rickey C, Kakuma T, Carroll MK, Kiosses D, Alexopoulos G. Predictors of early recovery from major depression among persons admitted to community-based clinics: an observational study. Arch Gen Psychiatry. 2002;59:729–35.PubMedCrossRef
21.
Weinberger MI, Sirey JA, Bruce ML, Heo M, Papademetriou E, Meyers BS. Predictors of major depression six months after admission for outpatient treatment. Psychiatr Serv. 2008;59:1211–5.PubMedPubMedCentralCrossRef
22.
Roy-Byrne P, Russo J, Dugdale DC, Lessler D, Cowley D, Katon W. Undertreatment of panic disorder in primary care: role of patient and physician characteristics. J Am Board Fam Pract. 2002;15:443–50.PubMed
23.
van Dijk MK, Oosterbaan DB, Verbraak MJ, van Balkom AJ. The effectiveness of adhering to clinical-practice guidelines for anxiety disorders in secondary mental health care: the results of a cohort study in the Netherlands. J Eval Clin Pract. 2013;19:791–7.PubMed
24.
Schüssler-Fiorenza Rose SM, Xie D, Streim JE, Pan Q, Kwong PL, Stineman MG. Identifying neuropsychiatric disorders in the Medicare Current Beneficiary Survey: the benefits of combining health survey and claims data. BMC Health Serv Res. 2016;16:537.PubMedPubMedCentralCrossRef
25.
26.
Préville M, Mechakra-Tahiri SD, Vasiliadis H-M, Mathieu V, Quesnel L, Gontijo-Guerra S, Lamoureux-Lamarche C, Berbiche D. Family violence among older adult patients consulting in primary care clinics: results from the ESA (Enquête sur la santé des aînés) Services Study on Mental Health and Aging. Can J Psychiatry. 2014;59:426–33.PubMedPubMedCentralCrossRef
27.
28.
Hudon C, Potvin O, Turcotte M-C, D’Anjou C, Dubé M, Préville M, Brassard J. Normalisation du Mini-Mental State Examination (MMSE) chez les Québécois francophones âgés de 65 ans et plus et résidant dans la communauté. Can J Aging. 2009;28:347–57.PubMedCrossRef
29.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef
30.
American Psychiatric Association: Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013.
31.
Blais R, Partlová H, Lachaine J, Sewitch M. La conformité aux guides de traitement de la dépression est-elle associée à une réduction des coûts des services de santé? Pratiques et Organisation des Soins. 2010;41:349–57.CrossRef
32.
Sewitch MJ, Blais R, Rahme E, Galarneau S, Bexton B. Pharmacologic response to a diagnosis of late-life depression: A population study in Quebec. Can J Psychiatry. 2006;51:363–70.PubMedCrossRef
33.
Alaghehbandan R, MacDonald D, Barrett B, Collins K, Chen Y. Using administrative databases in the surveillance of depressive disorders—case definitions. Popul Health Manag. 2012;15:372–80.PubMedCrossRef
34.
35.
36.
Supina AL, Johnson JA, Patten SB, Williams JV, Maxwell CJ. The usefulness of the EQ-5D in differentiating among persons with major depressive episode and anxiety. Qual Life Res. 2007;16:749–54.PubMedCrossRef
37.
Helvik A-S, Corazzini K, Selbæk G, Bjørkløf GH, Laks J, Benth JŠ, Østbye T, Engedal K. Health-related quality of life in older depressed psychogeriatric patients: one year follow-up. BMC Geriatr. 2016;16:131.PubMedPubMedCentralCrossRef
38.
Hajek A, Brettschneider C, Ernst A, Lange C, Wiese B, Prokein J, Weyerer S, Werle J, Pentzek M, Fuchs A. Complex coevolution of depression and health-related quality of life in old age. Qual Life Res. 2015;24:2713–22.PubMedCrossRef
39.
Diener E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess. 1985;49:71–5.PubMedCrossRef
40.
Blais MR, Vallerand RJ, Pelletier LG, Brière NM: L'échelle de satisfaction de vie: Validation canadienne-française du" Satisfaction with Life Scale. Can J Behav Sci 1989, 21:210.
41.
Canadian Coalition for Senior’s Mental Health: National Guidelines for Seniors’ Mental Health. The Assessment and Treatment of Depression. 2006.
42.
MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJV, Kennedy SH, Lam RW, Milev RV, Parikh SV: Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. special populations: youth, women, and the elderly. Can J Psychiatry 2016, 61:588–603.
43.
Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Kennedy SH, Lam RW, MacQueen GM: Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments. Can J Psychiatry 2016, 61:524–539.
44.
Turgeon M, Guénette L: Portrait de l'usage des antidépresseurs chez les adultes assurés par le régime public d'assurance médicaments du Québec: rapport final. Conseil du médicament; 2011.
45.
Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14:S1.PubMedPubMedCentralCrossRef
46.
Canadian Psychiatric Association: Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry 2006, 51:9S.
47.
Wolitzky-Taylor KB, Horowitz JD, Powers MB, Telch MJ. Psychological approaches in the treatment of specific phobias: A meta-analysis. Clin Psychol Rev. 2008;28:1021–37.PubMedCrossRef
48.
The American Geriatrics Society. Beers Criteria Update Expert Panel: American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;2012(60):616–31.CrossRef
49.
The American Geriatrics Society Beers Criteria® Update Expert Panel: American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;2019(67):674–94.
50.
Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36:1–10.PubMedCrossRef
51.
Pampalon R, Hamel D, Gamache P, Raymond G. A deprivation index for health planning in Canada. Chronic Dis Can. 2009;29:178–91.PubMedCrossRef
52.
Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand S-L, Walters EE, Zaslavsky AM. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959–76.PubMedCrossRef
53.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7.PubMedCrossRef
54.
Vézina J, Giroux L: L’Échelle des Embêtements: une étude de validation et d’adaptation du Hassles Scale pour une population adulte âgée. In Meeting of the Canadian Psychological Association, Montreal, June. 1988
55.
Mireault J, Lemay A: Analyses cliniques des hospitalisations de la population de ville de Laval et des patients de la Cité de la Santé de Laval, Montréal. Association des hôpitaux du Québec 1999, 113.
56.
Van Buuren S, Van Rijckevorsel JL. Imputation of missing categorical data by maximizing internal consistency. Psychometrika. 1992;57:567–80.CrossRef
57.
Bergstra SA, Sepriano A, Ramiro S, Landewé R: Three handy tips and a practical guide to improve your propensity score models. RMD open 2019, 5:e000953.
58.
Duhoux A, Fournier L, Nguyen CT, Roberge P, Beveridge R. Guideline concordance of treatment for depressive disorders in Canada. Soc Psychiatry Psychiatr Epidemiol. 2009;44:385.PubMedCrossRef
59.
Rizvi SJ, Grima E, Tan M, Rotzinger S, Lin P, McIntyre RS, Kennedy SH. Treatment-resistant depression in primary care across Canada. Can J Psychiatry. 2014;59:349–57.PubMedPubMedCentralCrossRef
60.
Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, Meredith LS, Rubenstein LV. The effect of adherence to practice guidelines on depression outcomes. Ann Intern Med. 2007;147:320–9.PubMedCrossRef
61.
Revicki DA, Simon GE, Chan K, Katon W, Heiligenstein J. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment. J Fam Pract. 1998;47:446–52.PubMed
62.
Chen P, Lin KC, Liing RJ, Wu CY, Chen CL, Chang KC. Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitation. Qual Life Res. 2016;25:1585–96.PubMedCrossRef
63.
Hu X, Jing M, Zhang M, Yang P, Yan X. Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study. Health Qual Life Outcomes. 2020;18:324.PubMedPubMedCentralCrossRef
64.
Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5:70.PubMedPubMedCentralCrossRef
65.
Sites BD, Masaracchia MM, Davis M. Distinguishing between efficacy and real-world effectiveness: the case for thinking beyond classic randomized controlled trial design. Reg Anesth Pain Med. 2017;42:131–2.PubMedCrossRef
66.
Zwarenstein M, Oxman A. Why are so few randomized trials useful, and what can we do about it? J Clin Epidemiol. 2006;59:1125–6.PubMedCrossRef
67.
Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?” Lancet. 2005;365:82–93.CrossRefPubMed
68.
Leichsenring F, Steinert C, Ioannidis JPA. Toward a paradigm shift in treatment and research of mental disorders. Psychol Med. 2019;49:2111–7.PubMedCrossRef
69.
Lindley RI. Drug Trials for Older People. The Journals of Gerontology: Series A. 2011;67A:152–7.CrossRef
70.
Butler AL, Smith M, Jones W, Adair CE, Vigod SN, Lesage A, Kurdyak P. Multi-province epidemiological research using linked administrative data: a case study from Canada. International Journal of Population Data Science. 2018;3:443.PubMedPubMedCentral
Metadata
Title
Treatment adequacy and remission of depression and anxiety disorders and quality of life in primary care older adults
Authors
Catherine Lamoureux-Lamarche
Djamal Berbiche
Helen-Maria Vasiliadis
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2021
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-021-01851-4

Other articles of this Issue 1/2021

Health and Quality of Life Outcomes 1/2021 Go to the issue

Research

Effects of foot massage on relieving pain, anxiety and improving quality of life of patients undergone a cervical spine surgery

Research

Determinants of health-related quality of life in patients with celiac disease: a structural equation modeling

Research

Health-related quality of life in a general population sample in Kazakhstan and its sociodemographic and occupational determinants

Research

Relationship between symptoms and both stage of change in adopting a healthy life style and quality of life in patients with liver cirrhosis: a cross-sectional study

Research

Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member

Research

Predictors of long-term HRQOL following cardiac surgery: a 5-year follow-up study